Literature DB >> 13042232

Toxic effects of phenylbutazone with special reference to disorders of the blood.

J C LEONARD.   

Abstract

Entities:  

Keywords:  ANALGESICS/injurious effects; BLOOD/effect of drugs on

Mesh:

Substances:

Year:  1953        PMID: 13042232      PMCID: PMC2016584          DOI: 10.1136/bmj.1.4823.1311

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Observations on the use of butazolidin in arthritis.

Authors:  H R DAVIES; R W BARTER; A GEE; C HIRSON
Journal:  Br Med J       Date:  1952-12-27

2.  Phenylbutazone (butazolidine) in the treatment of chronic arthritis.

Authors:  L CUDKOWICZ; J H JACOBS
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

3.  Agranulocytosis following use of phenylbutazone (butazolidin); report of a case.

Authors:  C HINZ; R W LAMONT-HAVERS; B COMINSKY; L M GAINES
Journal:  J Am Med Assoc       Date:  1953-01-03

4.  Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis.

Authors:  C A L STEPHENS; E E YEOMAN; W P HOLBROOK; D F HILL; W L GOODIN
Journal:  J Am Med Assoc       Date:  1952-11-15

5.  Phenylbutazone (butazolidin).

Authors:  W C KUZELL; R W SCHAFFARZICK
Journal:  Bull Rheum Dis       Date:  1952-11
  5 in total
  7 in total

1.  Multiple toxic effects of phenylbutazone; report of a fatal case.

Authors:  T N FRASER
Journal:  Br Med J       Date:  1955-05-28

2.  An appraisal of phenylbutazone suppositories.

Authors:  C F HAWKINS; H T FAWNS
Journal:  Br Med J       Date:  1959-10-17

3.  Aplastic anaemia due to phenylbutazone.

Authors:  G R VENNING
Journal:  Br Med J       Date:  1957-07-20

4.  The lymphocyte transformation test and gold hypersensitivity.

Authors:  E J Denman; A M Denman
Journal:  Ann Rheum Dis       Date:  1968-11       Impact factor: 19.103

5.  Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-29

6.  Aplastic anaemia due to phenylbutazone.

Authors:  A Cameron; A A Eisen; L M Niranjan
Journal:  Postgrad Med J       Date:  1966-01       Impact factor: 2.401

7.  Phenylbutazone (Bute, PBZ, EPZ): one drug across two species.

Authors:  Michael Worboys; Elizabeth Toon
Journal:  Hist Philos Life Sci       Date:  2018-03-26       Impact factor: 1.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.